Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-carnitine for vincristine-induced neurotoxicity in ALL
2005-001508-38Phase 2Terminated
- Sponsor
- Leadiant Biosciences
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetyl-l-carnitine in peripheral neuropathy and acute lymphoblastic leukemia (ALL), sponsored by Leadiant Biosciences. Started Sep 2007; status: terminated.
02
Drugs
acetyl-l-carnitine
03
Conditions
peripheral neuropathyacute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2005-001508-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001508-38.